Company: PHR
Filing Date: 2025-09-05
Form Type: 10-Q
Source: 0001412408-25-000062
Chunk: 17

Company: Phreesia, Inc.
Filing Date: 2025-09-05
Form: 10-Q
Item: Part II, Item 1A
Chunk 17
---
 business;

•the use of substantial portions of our available cash, issuance of our equity securities or incurrence of debt to consummate the acquisition;

•the loss of key employees, particularly those of the acquired operations; difficulty retaining or developing the acquired business’ customers;

•adverse effects on our existing business relationships;

•failure to realize the potential cost savings or other financial benefits or the strategic benefits of the acquisitions, including failure to consummate any proposed or contemplated transaction; and

•liabilities from the acquired businesses for infringement of intellectual property rights or other claims and failure to obtain indemnification for such liabilities or claims.

Acquisitions also increase the risk of unforeseen legal liability, including for potential violations of applicable law or industry rules and regulations, arising from prior or ongoing acts or omissions by the acquired businesses which are not discovered by due diligence during the acquisition process. Acquisitions could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our business, results of operations or financial condition. Even if we are successful in completing and integrating an acquired business, it may not perform as we expect or enhance the value of our business as a whole.

We may not consummate the AccessOne Acquisition within the expected time frame or at all.

The consummation of the AccessOne Acquisition is subject to a number of conditions, including expiration or termination of the waiting period pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act") and receipt of other approvals and consents. The transaction is expected to close during the third quarter or early fourth quarter of the fiscal year ending January 31, 2026, subject to the satisfaction or waiver of the closing conditions specified in the Merger Agreement. We can provide no assurance that the required approvals and consents will be obtained or that the required conditions to closing will be satisfied, and, if all required approvals are obtained and the required conditions are satisfied, we can give no assurance as to the terms, conditions and timing of such approvals.

The failure to satisfy all of the required conditions could delay the consummation of the AccessOne Acquisition for a significant period of time or prevent it from occurring at all. For example, under certain limited conditions, we and AccessOne may elect to terminate the Merger Agreement, including as a result of the financing contemplated by the Merger Agreement not being consummated, which could materially and adversely affect our business and reputation. A delay in consummating